← Eichor
Study identifier: NCT05913947 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)

Condition: Depression, Bipolar  ·  Sponsor: Aalborg University Hospital

PhasePhase 4
Planned participants122
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The goal is to study the effect of lithium compared to cariprazine in patients with depression in a bipolar disease. The main question it aims to answer is: Difference in change between the two groups from baseline to after 8 weeks treatment on Hamilton Ratings Scale for Depression, 6-item version (HDS-6) Participants will be randomized to treatment with either lithium or cariprazin. * Will meet for interview and ratings 4 times during study period. * In two meetings, there will be made blood samples and ECG. At one meeting also a Urine sample. * Will be contacted for telephone interviews at 6 occasions.

This description comes directly from the study's public registry record.

Talk to the study team

Sanne V. Hovgesen, MD  ·  +45 25487706  ·  sanne.hovgesen@rn.dk

Simon Johnsen, MsN  ·  +45 50589034  ·  simonjohnsen@rn.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Aalborg University HospitalAalborg, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05913947